Perrigo Price to Sales Ratio 2010-2024 | PRGO
Historical PS ratio values for Perrigo (PRGO) over the last 10 years. The current P/S ratio for Perrigo as of November 22, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Perrigo P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-21 | 27.08 | 0.84 | |
| 2024-09-30 | 26.23 | $32.10 | 0.82 |
| 2024-06-30 | 25.44 | $32.40 | 0.79 |
| 2024-03-31 | 31.89 | $33.36 | 0.96 |
| 2023-12-31 | 31.58 | $34.25 | 0.92 |
| 2023-09-30 | 31.08 | $34.29 | 0.91 |
| 2023-06-30 | 32.77 | $34.26 | 0.96 |
| 2023-03-31 | 34.33 | $33.86 | 1.01 |
| 2022-12-31 | 32.38 | $33.11 | 0.98 |
| 2022-09-30 | 33.60 | $32.80 | 1.02 |
| 2022-06-30 | 37.96 | $32.42 | 1.17 |
| 2022-03-31 | 35.73 | $31.43 | 1.14 |
| 2021-12-31 | 35.90 | $31.08 | 1.16 |
| 2021-09-30 | 43.39 | $30.10 | 1.44 |
| 2021-06-30 | 41.79 | $29.21 | 1.43 |
| 2020-12-31 | 40.32 | $29.76 | 1.36 |
| 2020-09-30 | 41.20 | $24.68 | 1.67 |
| 2020-06-30 | 49.39 | $24.90 | 1.98 |
| 2020-03-31 | 42.80 | $26.70 | 1.60 |
| 2019-12-31 | 45.78 | $27.23 | 1.68 |
| 2021-03-31 | 36.70 | $33.25 | 1.10 |
| 2019-09-30 | 49.32 | $34.39 | 1.43 |
| 2019-06-30 | 41.84 | $33.93 | 1.23 |
| 2019-03-31 | 42.11 | $34.07 | 1.24 |
| 2018-12-31 | 33.75 | $34.05 | 0.99 |
| 2018-09-30 | 61.66 | $34.40 | 1.79 |
| 2018-06-30 | 63.34 | $34.85 | 1.82 |
| 2018-03-31 | 72.21 | $34.93 | 2.07 |
| 2017-12-31 | 75.34 | $34.64 | 2.17 |
| 2017-09-30 | 73.04 | $34.93 | 2.09 |
| 2017-06-30 | 65.02 | $35.05 | 1.86 |
| 2017-03-31 | 57.04 | $35.77 | 1.59 |
| 2016-12-31 | 71.35 | $36.86 | 1.94 |
| 2016-09-30 | 79.02 | $20.57 | 3.84 |
| 2016-06-30 | 77.47 | $20.43 | 3.79 |
| 2016-03-31 | 109.15 | $17.94 | 6.08 |
| 2015-12-31 | 123.31 | $16.37 | 7.53 |
| 2015-09-30 | 133.91 | $30.45 | 4.40 |
| 2015-03-31 | 140.78 | $21.78 | 6.46 |
| 2014-12-31 | 142.03 | $22.39 | 6.34 |
| 2014-09-30 | 127.53 | $24.48 | 5.21 |
| 2014-06-30 | 123.68 | $27.25 | 4.54 |
| 2014-03-31 | 131.13 | $27.25 | 4.81 |
| 2013-12-31 | 130.03 | $29.51 | 4.41 |
| 2013-09-30 | 104.48 | $28.93 | 3.61 |
| 2013-06-30 | 102.39 | $27.24 | 3.76 |
| 2013-03-31 | 100.40 | $27.24 | 3.69 |
| 2012-12-31 | 87.89 | $25.77 | 3.41 |
| 2012-09-30 | 98.06 | $25.34 | 3.87 |
| 2012-06-30 | 99.47 | $24.90 | 4.00 |
| 2012-03-31 | 87.08 | $24.90 | 3.50 |
| 2011-12-31 | 81.95 | $24.02 | 3.41 |
| 2011-09-30 | 81.71 | $22.80 | 3.58 |
| 2011-06-30 | 73.88 | $21.95 | 3.37 |
| 2011-03-31 | 66.81 | $21.95 | 3.04 |
| 2010-12-31 | 53.15 | $20.37 | 2.61 |
| 2010-09-30 | 53.84 | $18.95 | 2.84 |
| 2010-06-30 | 49.47 | $17.73 | 2.79 |
| 2010-03-31 | 49.12 | $17.73 | 2.77 |
| 2009-12-31 | 33.28 | $17.35 | 1.92 |
| 2009-09-30 | 28.35 | $11.09 | 2.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.830B | $4.656B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.249B | 26.05 |
| Stryker (SYK) | United States | $146.711B | 33.06 |
| Boston Scientific (BSX) | United States | $132.644B | 38.14 |
| EssilorLuxottica (ESLOY) | France | $112.106B | 0.00 |
| Medtronic (MDT) | Ireland | $110.562B | 16.42 |
| Haleon (HLN) | United Kingdom | $43.682B | 28.38 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.166B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $37.665B | 19.54 |
| ResMed (RMD) | United States | $35.786B | 29.41 |
| Terumo (TRUMY) | Japan | $29.739B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.805B | 18.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.942B | 13.97 |
| Insulet (PODD) | United States | $18.443B | 73.44 |
| Baxter (BAX) | United States | $16.957B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.158B | 40.72 |
| Bio-Rad Laboratories (BIO) | United States | $9.320B | 31.68 |
| Demant (WILYY) | Denmark | $8.342B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.294B | 14.62 |
| TG Therapeutics (TGTX) | United States | $5.459B | 0.00 |
| Haemonetics (HAE) | United States | $4.297B | 20.97 |
| Prestige Consumer Healthcare (PBH) | United States | $4.192B | 20.85 |
| ICU Medical (ICUI) | United States | $4.125B | 39.27 |
| Envista Holdings (NVST) | United States | $3.697B | 27.54 |
| Neogen (NEOG) | United States | $3.246B | 37.45 |
| Agios Pharmaceuticals (AGIO) | United States | $3.175B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.841B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.700B | 17.38 |
| LeMaitre Vascular (LMAT) | United States | $2.428B | 59.00 |
| Warby Parker (WRBY) | United States | $2.349B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.913B | 33.48 |
| AtriCure (ATRC) | United States | $1.742B | 0.00 |
| InMode (INMD) | Israel | $1.597B | 9.61 |
| AdaptHealth (AHCO) | United States | $1.326B | 9.48 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.318B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.267B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.207B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.962B | 16.96 |
| Owens & Minor (OMI) | United States | $0.952B | 7.44 |
| CeriBell (CBLL) | United States | $0.943B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.918B | 30.68 |
| Capricor Therapeutics (CAPR) | United States | $0.847B | 0.00 |
| Evolus (EOLS) | United States | $0.798B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.684B | 30.25 |
| Omeros (OMER) | United States | $0.632B | 0.00 |
| Surmodics (SRDX) | United States | $0.563B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.533B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.522B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.468B | 0.00 |
| Quanterix (QTRX) | United States | $0.451B | 0.00 |
| ZimVie (ZIMV) | United States | $0.391B | 32.95 |
| Valneva SE (VALN) | France | $0.360B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.341B | 32.41 |
| Cerus (CERS) | United States | $0.332B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.330B | 0.00 |
| Biote (BTMD) | United States | $0.325B | 7.12 |
| OraSure Technologies (OSUR) | United States | $0.289B | 19.40 |
| Zynex (ZYXI) | United States | $0.263B | 55.07 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.221B | 15.29 |
| High Tide (HITI) | Canada | $0.213B | 88.33 |
| MacroGenics (MGNX) | United States | $0.203B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Brainsway (BWAY) | Israel | $0.167B | 100.00 |
| Organigram Holdings (OGI) | Canada | $0.166B | 0.00 |
| Jin Medical (ZJYL) | China | $0.164B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.160B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.149B | 18.67 |
| TriSalus Life Sciences (TLSI) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.104B | 11.74 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Veru (VERU) | United States | $0.099B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.40 |
| Ayr Wellness (AYRWF) | United States | $0.077B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.073B | 37.50 |
| Exagen (XGN) | United States | $0.072B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.065B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.062B | 0.00 |
| Modular Medical (MODD) | United States | $0.058B | 0.00 |
| MariMed (MRMD) | United States | $0.057B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| Safety Shot (SHOT) | United States | $0.051B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.018B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.83 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |